Joseph M. Paiva

Joseph M. Paiva

68 year
Health Technology
Consumer Services

Profile

Joseph M.
Paiva
, CPA Chief Financial Officer Mr. Paiva has been the Company's Chief Financial Officer since December 1997.
Prior thereto, Mr. Paiva was the Controller of Cephalon, Inc., an international biopharmaceutical company, from December 1995 to December 1997, the Chief Financial Officer of ActiMed Laboratories, Inc., a medical device company, from August 1994 to December 1995, and the Chief Financial Officer of Argus Pharmaceuticals, Inc., a publicly-traded biotechnology company, from September 1993 to April 1994.
Mr. Paiva was also employed by Cytogen Corporation, a biotechnology company, from September 1983 to September 1993 in a variety of positions of increasing responsibility, ultimately serving as Director of Finance and as Chief Financial Officer of its affiliated company, CytoRad Incorporated, a publicly-traded biotechnology company.
Mr. Paiva co-founded and served as past president of the Philadelphia-Princeton Chapter of the Association of Bioscience Financial Officers.
Mr. Paiva received a Bachelor of Science Degree in Accounting from Fairleigh Dickinson University in New Jersey and a Masters of Business Administration from Rutgers University in New Jersey.
Mr. Paiva is a Certified Public Accountant.

Former positions of Joseph M. Paiva

CompaniesPositionEnd
Corporate Officer/Principal 2007-06-03
Comptroller/Controller/Auditor -
See the detail of Joseph M. Paiva's experience

Training of Joseph M. Paiva

Fairleigh Dickinson University Undergraduate Degree
Rutgers State University of New Jersey Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joseph M. Paiva's experience

Connections

20

1st degree connections

4

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies2

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Joseph M. Paiva
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW